Theralase Technologies Inc. V.TLT

Finances

[jmm1228]

At this point to continue to solve liquidity needs by using private placement of warrants does not make much sense.

TLT is now on the threshold of establishing product  credibility and recognition which will open the doors to better executive oversight and financing opportunities. The foremost possibility is a takeover.

It is almost a given, IMO, that behind the scenes there is intense activity to establish financial strengths  to move this great science to prominence on a secure  platform.

Big Pharma is the obviously the best solutiion. The other options are full of issues which present way more challenge than TLT's management team can handle.

[DJDawg]

I hate do say it but I worry that the biggest issue may be management ego. One person in particular. How can you not raise money with some of this data. Unless you are keeping things under a tight wrap and don't want to lose any control of anything. I recall that a review on an employee website years ago indicated that the management due were micromanagers, and not very good ones. Just what I

[Rumpl3StiltSkin]

I think, after they gain FDA approval(AA) they can apply for a loan? Otherwise theyn yes, a JV or Buy Out are best.

[Eoganacht]

I vote for a JV. It would be a terrible shame to have a buyout at this stage of the game, when there is so much unexploited IP waiting in the wings. It's certainly not in shareholders' interest for Theralase to be bought out for a small fraction of it's value. And Roger Dumoulin-White is Theralase's biggest shareholder so it's not in his interest either.

[ScienceFirst]

Eoganacht ... A JV at this stage is THE solution.  It would bring upfront money as our NMIBC R&D and Ph. 2 data are worth something. A JV is the plan to then go demonstrate that our technology can also succeed in other indications.  That's the way it usually work in the industry.  A big pharma would have problem justifying paying let's say 10B$+ for something that has

[Eoganacht]

Absolutely. IMHO the next step is demonstrating proof of concept for low level radiation activation of rutherrin delivered systemically. If it works well with GBM and/or NSCLC this could open the door for even more cancer indications. And then there are all these new photosensitizers Dr. McFarland has been working on and Theralase has the rights to use. She has done a lot of work finding more

[stocksnbonds458]

Would a JV necessarily increase the share price appreciably? We would essentially be giving up a chunk of the company in return for working capital, however that may not move the stock price very much

[CAinPlap]

A JV would show that someone other than us believes in the future potential of out ACT and should move the needle considerably.

[Rumpl3StiltSkin]

Yes SnB, It should move the SP up nicely. Mainly because of the increased operating funds. Which will lead to GLP getting done for solid tumors etc. Phase 1s for GBM and NSCLS should move the needle again. I think SF was giving examples where the JV up front money was hundreds of $Million? I have no idea where TLT would go in a NMIBC JV...???

[N0taP00p]

When Medtronic gave TMDI (a Canadian robotic surgery startup with a very promising design but desperate for money)  $10M, everyone was excited that it was the beginning of a future JV or buyout of some kind. But it ended up that Medtronic only wanted some IP for their own platform. There was a temporary spike in share price but that's where it ended. TMDI was supposed to be some kind of

[Rumpl3StiltSkin]

I think at this point, given the CR numbers. TLT will own late stage NMIBC. I'm expecting a JV for that should bring in 9 figures. Enough for them to get a solid Phase 1 for NSCLS off the ground. Anyone think TLT will fail to get the BTD for this? And an AA afterwards?  Place your bets! :-)

[chry200030]

9 figures??? But I think you are short. Try 11 figures...

[Rumpl3StiltSkin]

A Buy Out, sure. But a JV for just NMIBC? Hmm, to dream...

[CancerSlayer]

  If the company partners with Big Pharma (JV), I only hope we get fair value.  For a small biotech like ours, I'm not sure a BTD is enough derisking to get a generous enough deal from Big Pharma, at least for us retail investors.  Big Pharma will certainly use its bargaining power strength, & it very well knows it stands to gain much more with an early stage deal (buyout

[BlueFranky]

Thanks CS, for that reassuring shot in the arm - much appreciated Have a great weekend!

[N0taP00p]

Great perspectives, Slayer. There's  blood and sweat for sure to get us this far. Can't fault that. However, I feel there's a point at which you may need an industry veteran to take this forward. Someone that is detached from the science and focuses on capital, industry and shareholder outreach, operations (including manufacturing and procurement), funding and priorities for

[Oilminerdeluxe]

The company has worked on fumes before but realistically, how much  is left in the bank now? That 1,5M must be drained very thin. Any raise at these prices will sting, so I wish it won't be a big one. Perhaps after the next data update?

[Rumpl3StiltSkin]

Yep OMD, Hoping for a small raise. If not around next update maybe around AGM?

[Infinity]

I agree with your perspective about getting it into higher gears.  We have been grinding along for way too long at below $0.50.   Our Management clearly believes we are close to BTD and possibly even AA.  I would very much wait for BTD and AA with a small raise via PP.  I believe a reverse split is never a good idea for a penny stock to increase the price instead of

[Rumpl3StiltSkin]

Indeed Slayer,  Wish I had some more $$$$ to buy with at these levels.

[enriquesuave]

With the right price anything is possible, but most likely a BO after PH1 from at least another indication.  IMO

[2b7f6fab]

If a BO with big pharma occurs I hope it involves a stock swap and not cash.  Short term capital gains tax on the warrants would be much higher than long term capital gains tax rate.

[Rumpl3StiltSkin]

I think for warrants the acquiring company would give us equivilant warrants in their company?